October 12, 2022 · STOCK Act disclosure
Representative Chris Jacobs (Republican-NY) bought Amylyx Pharmaceuticals, Inc., a stock transaction, valued at $1,001 - $15,000. The trade took place on October 12, 2022 and was disclosed on November 16, 2022 (owner: Self). Members of Congress must report such transactions within 45 days under the STOCK Act.